BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 2200957)

  • 1. Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potential.
    Butterworth BE
    Mutat Res; 1990 Sep; 239(2):117-32. PubMed ID: 2200957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
    Ashby J; Paton D
    Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anomalous nonidentity between Salmonella genotoxicants and rodent carcinogens: nongenotoxic carcinogens and genotoxic noncarcinogens.
    Yoshikawa K
    Environ Health Perspect; 1996 Jan; 104(1):40-6. PubMed ID: 8834860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project.
    Yamasaki H; Ashby J; Bignami M; Jongen W; Linnainmaa K; Newbold RF; Nguyen-Ba G; Parodi S; Rivedal E; Schiffmann D; Simons JW; Vasseur P
    Mutat Res; 1996 Jun; 353(1-2):47-63. PubMed ID: 8692192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
    Butterworth BE; Conolly RB; Morgan KT
    Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemically induced cell proliferation in carcinogenesis.
    Butterworth BE; Popp JA; Conolly RB; Goldsworthy TL
    IARC Sci Publ; 1992; (116):279-305. PubMed ID: 1428087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxicity and carcinogenicity studies of bronchodilators and antiasthma drugs.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Basic Clin Pharmacol Toxicol; 2013 May; 112(5):302-13. PubMed ID: 23374861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are genotoxic carcinogens more potent than nongenotoxic carcinogens?
    Parodi S; Malacarne D; Romano P; Taningher M
    Environ Health Perspect; 1991 Nov; 95():199-204. PubMed ID: 1821372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxic and carcinogenic effects of gastrointestinal drugs.
    Brambilla G; Mattioli F; Martelli A
    Mutagenesis; 2010 Jul; 25(4):315-26. PubMed ID: 20478972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential biomarkers of genotoxicity and carcinogenicity in L5178Y mouse lymphoma cells by cDNA microarray analysis.
    Kim JY; Kwon J; Kim JE; Koh WS; Chung MK; Yoon S; Song CW; Lee M
    Environ Mol Mutagen; 2005; 45(1):80-9. PubMed ID: 15612046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic events during the process of cell transformation induced by carcinogens (review).
    Nguyen-Ba G; Vasseur P
    Oncol Rep; 1999; 6(4):925-32. PubMed ID: 10373683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity.
    Ellinger-Ziegelbauer H; Aubrecht J; Kleinjans JC; Ahr HJ
    Toxicol Lett; 2009 Apr; 186(1):36-44. PubMed ID: 18822359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of genotoxic chemicals among animal and human carcinogens evaluated in the IARC Monograph Series.
    Bartsch H; Malaveille C
    Cell Biol Toxicol; 1989 Jun; 5(2):115-27. PubMed ID: 2766027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.